Clinical Application of Artificial Intelligence in Ultrasound Imaging for Oncology.

IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL
JMA journal Pub Date : 2025-01-15 Epub Date: 2024-09-27 DOI:10.31662/jmaj.2024-0203
Masaaki Komatsu, Naoki Teraya, Takashi Natsume, Naoaki Harada, Katsuji Takeda, Ryuji Hamamoto
{"title":"Clinical Application of Artificial Intelligence in Ultrasound Imaging for Oncology.","authors":"Masaaki Komatsu, Naoki Teraya, Takashi Natsume, Naoaki Harada, Katsuji Takeda, Ryuji Hamamoto","doi":"10.31662/jmaj.2024-0203","DOIUrl":null,"url":null,"abstract":"<p><p>Ultrasound (US) imaging is a widely used tool in oncology because of its noninvasiveness and real-time performance. However, its diagnostic accuracy can be limited by the skills of the examiner when performing manual scanning and by the presence of acoustic shadows that degrade image quality. Artificial intelligence (AI) technologies can support examiners in cancer screening and diagnosis by addressing these limitations. Here, we examine recent advances in AI research and development for US imaging in oncology. Breast cancer has been the most extensively studied cancer, with research predominantly focusing on tumor detection, differentiation between benign and malignant lesions, and prediction of lymph node metastasis. The American College of Radiology developed a medical imaging reporting and data system for various cancers that is often used to evaluate the accuracy of AI models. We will also explore the application of AI in clinical settings for US imaging in oncology. Despite progress, the number of approved AI-equipped software as medical devices for US imaging remains limited in Japan, the United States, and Europe. Practical issues that need to be addressed for clinical application include domain shifts, black boxes, and acoustic shadows. To address these issues, advances in image quality control, AI explainability, and preprocessing of acoustic shadows are essential.</p>","PeriodicalId":73550,"journal":{"name":"JMA journal","volume":"8 1","pages":"18-25"},"PeriodicalIF":1.5000,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11799696/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JMA journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31662/jmaj.2024-0203","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/27 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Ultrasound (US) imaging is a widely used tool in oncology because of its noninvasiveness and real-time performance. However, its diagnostic accuracy can be limited by the skills of the examiner when performing manual scanning and by the presence of acoustic shadows that degrade image quality. Artificial intelligence (AI) technologies can support examiners in cancer screening and diagnosis by addressing these limitations. Here, we examine recent advances in AI research and development for US imaging in oncology. Breast cancer has been the most extensively studied cancer, with research predominantly focusing on tumor detection, differentiation between benign and malignant lesions, and prediction of lymph node metastasis. The American College of Radiology developed a medical imaging reporting and data system for various cancers that is often used to evaluate the accuracy of AI models. We will also explore the application of AI in clinical settings for US imaging in oncology. Despite progress, the number of approved AI-equipped software as medical devices for US imaging remains limited in Japan, the United States, and Europe. Practical issues that need to be addressed for clinical application include domain shifts, black boxes, and acoustic shadows. To address these issues, advances in image quality control, AI explainability, and preprocessing of acoustic shadows are essential.

人工智能在肿瘤超声成像中的临床应用
超声成像因其无创性和实时性而被广泛应用于肿瘤学。然而,它的诊断准确性可能会受到检查人员在进行手动扫描时的技能和降低图像质量的声阴影的存在的限制。人工智能(AI)技术可以通过解决这些限制来支持检查人员进行癌症筛查和诊断。在这里,我们研究了美国肿瘤学成像中人工智能研究和开发的最新进展。乳腺癌一直是研究最广泛的癌症,研究主要集中在肿瘤的检测、良恶性病变的鉴别、淋巴结转移的预测等方面。美国放射学会(American College of Radiology)开发了针对各种癌症的医学影像报告和数据系统,该系统通常用于评估人工智能模型的准确性。我们还将探讨人工智能在肿瘤学超声成像的临床应用。尽管取得了进展,但在日本、美国和欧洲,批准的配备人工智能的软件作为美国成像医疗设备的数量仍然有限。临床应用中需要解决的实际问题包括域移位、黑盒和声学阴影。为了解决这些问题,在图像质量控制、人工智能可解释性和声阴影预处理方面取得进展至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信